A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer
Clinical trial NCT01017874 · COMPLETED
Trial details
- NCT number
- NCT01017874
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2013-04-01
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.